US Broker Ratings

Teladoc Health, Inc. (TDOC) Stock Analysis: Navigating Uncharted Waters with a 22% Potential Upside

Teladoc Health, Inc. (NYSE: TDOC) stands as a pivotal player in the rapidly evolving healthcare sector, specifically within the health information services industry. With a market capitalization of $1.14 billion,..

NovoCure Limited (NVCR) Stock Analysis: Unpacking the 64% Potential Upside in the Medical Device Sector

Investors interested in the intersection of cutting-edge technology and healthcare might find NovoCure Limited (NASDAQ: NVCR) an intriguing prospect. Specializing in innovative oncology solutions, this Swiss-based medical device company is..

Indivior Pharmaceuticals (INDV) Stock Analysis: Exploring a 37.91% Potential Upside

Indivior Pharmaceuticals, Inc. (NASDAQ: INDV) has become a compelling prospect for investors seeking exposure in the healthcare sector, particularly within the niche of drug manufacturers specializing in treatments for opioid..

Azenta, Inc. (AZTA) Investor Outlook: Analyzing Growth Potential Amidst a 4.44% Upside

Azenta, Inc. (NASDAQ: AZTA), a key player in the Healthcare sector under the Medical Instruments & Supplies industry, presents intriguing opportunities for investors with its innovative solutions in the life..

Neogen Corporation (NEOG) Stock Analysis: What Investors Need to Know About Its Market Position and Growth Potential

Neogen Corporation (NASDAQ: NEOG), with its focus on food and animal safety, stands as a notable player in the healthcare sector, particularly within the medical devices industry. Headquartered in Lansing,..

Progyny, Inc. (PGNY) Investor Outlook: Evaluating the 28% Upside Potential

Progyny, Inc. (NASDAQ: PGNY) presents a compelling opportunity for investors keen on the healthcare sector, particularly within the growing niche of fertility and family health benefits management. With its headquarters..

National HealthCare Corporation (NHC) Stock Analysis: Stability and Growth in Healthcare Facility Operations

National HealthCare Corporation (NYSE: NHC) is a prominent player in the healthcare sector, specializing in the management and operation of a wide range of medical care facilities across the United..

Liquidia Corporation (LQDA): Investor Outlook Highlights 62.20% Potential Upside Amidst Robust Revenue Growth

Liquidia Corporation (NASDAQ: LQDA), a promising player in the biopharmaceutical industry, has captured the attention of investors with its innovative approach to treating rare cardiopulmonary diseases. With a market capitalization..

ImmunityBio, Inc. (IBRX) Stock Analysis: Exploring a 50.89% Upside in the Biotech Sector

ImmunityBio, Inc. (NASDAQ: IBRX), a prominent player in the biotechnology sector, is currently capturing investor attention with its significant growth potential. With a market capitalization of $8.96 billion and a..

PACS Group, Inc. (PACS) Stock Analysis: Exploring a 40% Potential Upside in Healthcare Facilities

PACS Group, Inc. (PACS), a prominent player in the healthcare sector, specifically within the medical care facilities industry, is catching the attention of individual investors with its robust growth potential...

LivaNova PLC (LIVN) Stock Analysis: A Healthcare Innovator with a 13.98% Upside Potential

LivaNova PLC (NASDAQ: LIVN), a leading player in the healthcare sector’s medical devices industry, offers investors a compelling growth story underpinned by its innovative product offerings and robust market presence...

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring a 62.88% Potential Upside with Strong Buy Ratings

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a key player in the medical devices sector, is making waves with its innovative solutions for diabetes management. Headquartered in San Diego, California, Tandem..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: A Biotech Innovator with Significant Upside Potential

Scholar Rock Holding Corporation (NASDAQ: SRRK), a pioneering biopharmaceutical company, presents a compelling opportunity for investors looking to capitalize on the healthcare sector’s potential, particularly within the biotechnology industry. With..

Vera Therapeutics, Inc. (VERA) Stock Analysis: A Biotechnology Player with 126% Upside Potential

For investors with an eye on the biotechnology sector, Vera Therapeutics, Inc. (NASDAQ: VERA) presents an intriguing opportunity. The company, with a market capitalization of $2.47 billion, is making strides..

Harmony Biosciences Holdings (HRMY): Stock Analysis Reveals 12.5% Potential Upside in Biotech Sector

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is making waves in the biotechnology sector with its innovative approach to treating rare neurological diseases. Based in Plymouth Meeting, Pennsylvania, Harmony Biosciences is..

Adaptive Biotechnologies Corp (ADPT) Stock Analysis: A Closer Look at Its 21.5% Revenue Growth and Market Potential

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) stands at the forefront of the healthcare sector with its innovative approach to diagnostics and research. The Seattle-based company, which was originally established as Adaptive..

CONMED Corporation (CNMD) Stock Analysis: Potential Upside and Analyst Ratings Highlight Investment Considerations

Investors eyeing opportunities in the healthcare sector should take a closer look at CONMED Corporation (CNMD), a medical technology company with a robust portfolio of innovative surgical devices. With a..

Ligand Pharmaceuticals (LGND): Analyst Consensus and Growth Potential in the Biotech Arena

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) stands as a notable player in the biotechnology sector, with a market capitalization of $5.78 billion. This U.S.-based biopharmaceutical company has carved out a niche..

Clover Health Investments, Corp (CLOV): Exploring the 18.39% Potential Upside and Analyst Ratings

Clover Health Investments, Corp (NASDAQ: CLOV) is capturing investor attention with its promising growth prospects in the healthcare sector. With a market capitalization of $2.41 billion, CLOV operates primarily in..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Exploring a 35% Potential Upside and Robust Growth Prospects

LeMaitre Vascular, Inc. (NASDAQ: LMAT) is a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $1.81 billion, this U.S.-based..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds